Filter By Industry
Filter By Tag

Newsroom

Corporate Ads Press releases

11 - 19 of 19 Press Releases

AI Team from "PersonalAIze" Expert Assessment; Groundbreaking AI Platform Starting with Early Cancer Detection: Renovaro; Stock Symbol: RENB
Sep 17, 2024
PersonalAIze, a cutting-edge company in AI and machine learning applications for healthcare, has conducted a comprehensive evaluation of the RENB RenovaroCube's advanced AI platform.

Diversified Industrial Acquisition Agreement, Plus Major Contract Award for Large Fleet Trucking Provider: MingZhu Logistics: Stock Symbol: YGMZ
Sep 12, 2024
$YGMZ Plans to Acquire HOLDCO 36 in Transformational Business Combination

NRx Pharmaceuticals NRXP: Prominently Featured in Psychiatrist.com; Article Titled "How NRx Could Upend the Fight Against Depression and Suicide"
Sep 10, 2024
Substantial Funding Agreements, Debt Resolution and Successful Clinical Trial Progress Towards Accelerated Drug Approval

Planned Spin-Out to Focus on Gene Therapy for Type 1 and 2 Diabetes in Parallel to Treatments for Late Stage Lung Cancer: Genprex: Stock Symbol: GNPX
Sep 04, 2024
Genprex Stock Symbol: GNPX is Gene Therapy Focused on Life-Changing Developments for Cancer and Diabetes

Powerhouse Staffing Solutions Provider Completes Merger with Lyneer, Creating a Top 40 U.S. Staffing Firm: Atlantic Intl. Corp. (Stock Symbol: ATLN)
Aug 27, 2024
$ATLN Delivering Over $400 Million in Annual Revenue with 2025 Growth Projections Over $1 Billion

Popular China Based Amusement Park Operator Expands With Scenic Plot Deal for New Amusement Complex: Golden Heaven Group Holdings (Stock Symbol: GDHG)
Aug 27, 2024
GDHG operates amusement parks, water parks and complementary recreational facilities

Acquisition of Clinics Generating $100 Million to Complement Progress on Accelerated Drug Approval for Bipolar Depression NRx Pharmaceuticals: NRXP
Aug 26, 2024
NRXP: Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Clinics.

Positive Clinical Results with Promising Gene Therapy Treatment for Late Stage Lung Cancer; Life-Changing Developments for Cancer & Diabetes: GNPX
Aug 21, 2024
Working With World-Class Institutions/Collaborators to Provide Novel Treatment Approaches. Stock Symbol: GNPX

Substantial Funding, Debt Resolution, HOPE Dividend, Successful Clinical Trial Towards Accelerated Drug Approval for Bipolar Depression: Nasdaq: NRXP
Aug 14, 2024
HOPE Therapeutic Subsidiary Focused on Developing a Best-in-Class Network of Clinics for Patients with Suicidal Depression and Related Disorders. HOPE is Planned to be Spun Out as a Separate Company to be Owned by NRXP Shareholders, and New Investors.


Page: Prev 1 2
Corporate Ads RSS Feed